Pharmacy Usual Items - Iraq

  • Iraq
  • Revenue in the Pharmacy Usual Items market is projected to reach US$0.70bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 4.92%, resulting in a market volume of US$0.89bn by 2029.
  • In global comparison, most revenue will be generated in China (US$48,050.00m in 2024).
  • In relation to total population figures, per person revenues of US$14.98 are generated in 2024.

Key regions: Japan, France, China, Australia, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Pharmacy Usual Items market in Iraq is experiencing significant growth and development.

Customer preferences:
Customers in Iraq have a strong preference for pharmacy usual items, which include over-the-counter medications, vitamins, and personal care products. These items are essential for maintaining good health and well-being, and customers rely on them for their everyday needs. With limited access to healthcare facilities and a lack of insurance coverage, many Iraqis turn to pharmacies as their primary source of healthcare. As a result, the demand for pharmacy usual items remains high in the country.

Trends in the market:
One of the key trends in the Pharmacy Usual Items market in Iraq is the increasing availability and variety of products. Pharmacies are expanding their product offerings to cater to the diverse needs of customers. This includes stocking a wide range of medications, vitamins, and personal care products from both local and international brands. The market is also witnessing a growing trend of online pharmacies, which provide convenience and accessibility to customers, especially in remote areas where access to physical pharmacies may be limited. Another trend in the market is the rising demand for natural and organic products. Customers in Iraq are becoming more health-conscious and are seeking natural alternatives to traditional medications and personal care products. This has led to an increase in the availability of natural and organic pharmacy usual items in the market. Pharmacies are responding to this trend by sourcing and stocking products that cater to this growing demand.

Local special circumstances:
The Pharmacy Usual Items market in Iraq is influenced by several local special circumstances. One of the key factors is the ongoing political instability in the country. Iraq has faced years of conflict and instability, which has had a significant impact on its healthcare system. The lack of infrastructure and resources has led to a reliance on pharmacies for basic healthcare needs. This has created a unique market environment where pharmacies play a crucial role in providing essential healthcare products to the population.

Underlying macroeconomic factors:
The growth and development of the Pharmacy Usual Items market in Iraq can be attributed to several underlying macroeconomic factors. The country has experienced steady economic growth in recent years, which has led to an increase in disposable income among the population. This has allowed customers to spend more on healthcare products, including pharmacy usual items. Additionally, the growing middle class in Iraq has contributed to the rising demand for quality healthcare products. As the middle class continues to expand, the market for pharmacy usual items is expected to grow further. In conclusion, the Pharmacy Usual Items market in Iraq is developing rapidly due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The demand for pharmacy usual items remains high, driven by the reliance on pharmacies for healthcare needs and the increasing availability and variety of products. As the country continues to stabilize and the economy grows, the market is expected to expand further, providing opportunities for both local and international players in the industry.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)